Access the full text.
Sign up today, get DeepDyve free for 14 days.
V. Mijatovic, C. Netelenbos, M. Mooren, G. Roo, C. Jakobs, P. Kenemans (1998)
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.Fertility and sterility, 70 6
Chiamvimonvat (1998)
Coronary artery disease in womenCan Fam Physician, 44
T. Beljić, D. Babic, J. Marinkovic, G. Prelević (1998)
The effect of hormone replacement therapy on diastolic left ventricular function in hypertensive and normotensive postmenopausal women.Maturitas, 29 3
A. Pines, E. Fisman, D. Ayalon, Y. Drory, M. Averbuch, Y. Levo (1992)
Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women.Chest, 102 5
Hilda Kessel, O. Kamp, Peter Kenemans, Velja Mijatovic, W. Baal, Cees Visser, M. Mooren (2001)
Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.American journal of obstetrics and gynecology, 184 5
Pines (1996)
Left ventricular function during a short-term transdermal estradiol therapy in postmenopausal women: a double-blind placebo-controlled echocardiographic studyEur Menopause J, 3
A. Fak, M. Erenus, H. Tezcan, O. Caymaz, Ş. Oktay, A. Oktay (2000)
Effects of a single dose of oral estrogen on left ventricular diastolic function in hypertensive postmenopausal women with diastolic dysfunctionFertility and Sterility, 73
O. Taskin, R. Gökdeniz, H. Muderrisoglu, M. Korkmaz, I. Uryan, R. Atmaca, A. Kafkasli (1998)
The effects of hormone replacement therapy on echocardiographic basic cardiac functions in postmenopausal women.Human reproduction, 13 9
K. Light, A. Hinderliter, S. West, K. Grewen, J. Steege, A. Sherwood, S. Girdler (2001)
Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal womenJournal of Hypertension, 19
S. Goldstein (1998)
Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women.American journal of obstetrics and gynecology, 179 6 Pt 1
M. Snabes, J. Payne, H. Kopelen, Dunnick Jk, R. Young, W. Zoghbi (1997)
Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebo- controlled, crossover trialObstetrics & Gynecology, 89
Steven Cummings, Stephen Eckert, Kathryn Krueger, Deborah Grady, T. Powles, J. Cauley, Larry Norton, Thomas Nickelsen, Nina Bjarnason, Monica Morrow, Marc Lippman, Dennis Black, J. Glusman, Alberto Costa, V. Jordan (1999)
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.JAMA, 281 23
S. Voutilainen, M. Hippeläinen, S. Hulkko, K. Karppinen, M. Ventilä, M. Kupari (1993)
Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women.The American journal of cardiology, 71 7
P. Delmas, N. Bjarnason, B. Mitlak, Anne-Catherine Ravoux, A. Shah, W. Huster, M. Draper, C. Christiansen (1997)
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.The New England journal of medicine, 337 23
M. Lee, E. Giardina, S. Homma, M. DiTullio, R. Sciacca (1997)
Lack of effect of estrogen on rest and treadmill exercise in postmenopausal women without known cardiac disease.The American journal of cardiology, 80 6
M. Legato (1996)
Coronary artery disease in women.International journal of fertility and menopausal studies, 41 2
G. Prelević, T. Beljić (1994)
The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women.Maturitas, 20 1
A. Pearlman, J. Gardin, Randolph Martin, A. Parisi, R. Popp, M. Quiñones, J. Stevenson (1988)
Guidelines for Optimal Physician Training in Echocardiography: Recommendations of the American Society of Echocardiography Committee for Physician Training in EchocardiographyJournal of The American Society of Echocardiography, 1
Pearlman (1987)
Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography Committee for Physician Training in EchocardiographyAm J Cardiol, 60
A. Pines, E. Fisman, Y. Levo, M. Averbuch, A. Lidor, Y. Drory, A. Finkelstein, M. Hetman-Peri, M. Moshkowitz, E. Ben-Ari, D. Ayalon (1991)
The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow.American journal of obstetrics and gynecology, 164 3
Eugenia Calle, C. Heath, R. Coates, J. Liff, Silvia Franceschi, R. Talamini, N. Chantarakul, Suporn Koetsawang, D. Rachawat, A. Morabia, L. Schuman, W. Stewart, M. Szklo, Chris Bain, F. Schofield, Victor Siskind, P. Band, A. Coldman, Richard Gallagher, T. Hislop, P. Yang, Stephen Duffy, Laurence Kolonel, A. Nomura, M. Oberle, H. Ory, Herbert Peterson, H. Wilson, P. Wingo, K. Ebeling, D. Kunde, P. Nishan, Graham Colditz, Nicholas Martin, T. Pardthaisong, S. Silpisornkosol, C. Theetranont, B. Boosiri, S. Chutivongse, P. Jimakorn, P. Virutamasen, C. Wongsrichanalai, A. McMichael, T. Rohan, M. Ewertz, Carle Paul, D. Skegg, G. Spears, Peter Boyle, M. Evstifeeva, J. Daling, W. Hutchinson, K. Malone, E. Noonan, J. Stanford, D.B. Thomas, N. Weiss, E. White, Nadine Andrieu, A. Bràmond, F. Clavel, B. Gairard, J. Lansac, L. Piana, R. Renaud, S. Fine, H. Cuevas, P. Ontiveros, A. Palet, S. Salazar, N. Aristizabel, A. Cuadros, A. Bachelot, M. Lê, J. Deacon, J. Peto, C. Taylor, E. Alfandary, Baruch Modan, Elaine Ron, G. Friedman, Robert Hiatt, T. Bishop, J. Kosmelj, M. Primic‐Žakelj, B. Ravnihar, J. Stare, W. Beeson, Graeme Fraser, R. Bulbrook, J. Cuzick, I. Fentiman, J. Hayward, D. Wang, R. Hanson, M. Leske, M. Mahoney, P. Nasca, A. Varma, A. Weinstein, Torgil Möller, Hampus Olsson, J. Ranstam, R. Goldbohm, P. Brandt, R. Apelo, J. Baens, J. Cruz, B. Javier, L. Lacaya, C. Ngelangel, C. Vecchia, E. Negri, Ettore Marubini, M. Ferraroni, Mariette Gerber, S. Richardson, C. Ségala, D. Gatei, P. Kenya, A. Kungu, J. Mati, L. Brinton, R. Hoover, C. Schairer, R. Spirtas, H. Lee, M. Rookus, F. Leeuwen, J. Schoenberg, M. Gammon, E. Clarke, L. Jones, Klim McPherson, A. Neil, M. Vessey, D. Yeates, V. Beral, D. Bull, B. Crossley, C. Hermon, S. Jones, Timothy Key, C. Lewis, G. Reeves, R. Collins, R. Doll, R. Peto, P. Hannaford, CliffordR. Kay, L. Rosero-Bixby, Jian-Min Yuan, H. Wei, T. Yun, C. Zhiheng, G. Berry, J. Booth, T. Jelihovsky, R. Maclennan, R. Shearman, Q. Wang, C. Baines, A. Miller, C. Wall, E. Lund, H. Stalsberg, A. Dabancens, L. Martínez, R. Molina, O. Salas, Freda Alexander, B. Hulka, C. Chilvers, L. Bernstein, R. Haile, A. Paganini-Hill, M. Pike, R. Ross, G. Ursin, Mimi Yu, M. Longnecker, P. Newcomb, T. Farley, S. Holck, O. Meirik, H. Adami, R. Bergkvist, I. Persson, F. Levi, Kiyohiko Mabuchi, D. Preston, K. Katsouyanni, A. Trichopoulou, D. Trichopoulos, L. Bergkvist (1997)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 350
Amos Pines, E. Fisman, Itzhak Shapira, Yaacov Drory, Avraham Weiss, Nachman Eckstein, Y. Levo, M. Averbuch, M. Motro, Heshi Rotmensch, Daniel Ayalon (1996)
Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension.The American journal of cardiology, 78 12
V. Mijatovic, M. Mooren, P. Kenemans, G. Roo, C. Netelenbos (1999)
Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.Menopause, 6 2
S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, E. Vittinghoff (1998)
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.JAMA, 280 7
Brian Walsh, S. Paul, Robert Wild, Robert Dean, Russell Tracy, David Cox, Pamela Anderson (2000)
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.The Journal of clinical endocrinology and metabolism, 85 1
C. Sites, M. Tischler, J. Blackman, J. Niggel, J. Fairbank, M. O'connell, T. Ashikaga (1999)
Effect of short-term hormone replacement therapy on left ventricular mass and contractile function.Fertility and sterility, 71 1
E. Barrett-Connor, D. Grady (1998)
Hormone replacement therapy, heart disease, and other considerations.Annual review of public health, 19
Objective: Our purpose was to investigate the long-term effects of raloxifene, compared with opposed and unopposed estrogen replacement therapy, on echocardiographic parameters of left ventricular systolic function in healthy postmenopausal women. A total of 157 women were studied in 2 randomized, double-blind, placebo-controlled, 2-year studies. Study design: In study I, 60 postmenopausal women who had undergone hysterectomy received daily raloxifene, 60 mg (n = 15); raloxifene, 150 mg (n = 15); conjugated equine estrogens (CEE), 0.625 mg (n = 15); or placebo (n = 15). In study II, 97 postmenopausal women who had not undergone hysterectomy received daily raloxifene, 60 mg (n = 24); raloxifene, 150 mg (n = 24); CEE, 0.625 mg, plus medroxyprogesterone acetate (MPA), 2.5 mg (n = 24); or placebo (n = 25). M-mode, quantitative 2-dimensional and Doppler echocardiographic measurements were performed at baseline and after 1 and 2 years. Results: Neither after 1 year nor after 2 years of treatment were echocardiographic parameters found to differ from baseline in both raloxifene groups, as well as in the unopposed CEE and the CEE/MPA groups, compared with the placebo group. Conclusion: Within 2 years of raloxifene treatment, no effect on echocardiographic parameters of left ventricular systolic function was found. Unopposed CEE or CEE/MPA also showed no effect. (Am J Obstet Gynecol 2002;186:729-36.)
American Journal of Obstetrics and Gynecology – Wolters Kluwer Health
Published: Apr 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.